Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers Construct Computer Simulations of Laser-Nanoparticle Treatments

By LabMedica International staff writers
Posted on 16 Jun 2009
Two lasers may be better than one when attacking cancer cells, according to a recent report.

Dr. More...
Yildiz Bayazitoglu, a professor of mechanical engineering from Rice University (Houston, TX, USA) and a specialist on heat transfer and fluid flow, and doctoral student Jerry Vera are using computer simulations to quantify the effect of heating nanoparticles with near-infrared lasers to destroy cancer tumors without damaging healthy tissue.

The investigators hope to increase the effectiveness of destroying tumors by modifying methods of heating them based on the size and composition of not only the tumor but also the surrounding tissue. The study was published in the January 2009 issue of the International Journal of Heat and Mass Transfer.

The researchers revealed that attacking a tumor with two lasers could heat it more thoroughly than a single laser. For tumors as large as 1 cm, simulations showed opposing lasers surgically inserted via fiberoptics in a minimally invasive procedure generated the most uniform temperature profile in every case.

Lasers and nanoparticles are already being used to treat cancer. A company founded by Rice scientists Drs. Jennifer West and Naomi Halas, Nanospectra Biosciences, Inc. (Houston, TX, USA), is conducting human tests of a system that uses nanoshells heated by near-infrared lasers to kill tumors. Drs. Bayazitoglu, West, and Halas are all part of Rice's Laboratory for Nanophotonics.

The Bayazitoglu group's approach would refine such treatment by taking into account the light-scattering properties of nanoparticles. Their concern is that nanoparticles near the surface of a tumor will block a laser from reaching those at the center. "Think about it this way: If you're driving on a very foggy night, you can only see just so far no matter how good your headlights are,” commented Dr. Vera. "That's because the millions of small water droplets in the air absorb and scatter the light, deflecting the beams from your headlights before they can reflect off of whatever's ahead of you on the road. Nanoparticles dispersed within a tumor do exactly the same thing. They're very good at absorbing laser light and generating heat, but within particularly thick tumors, that same quality prevents a lot of the light from reaching deeper into the tissue.”

Dr. Bayazitoglu reported that this phenomenon, called "extinction,” is "highly undesirable.” A uniform temperature profile of at least 60 oC has to be created to kill the whole tumor. "Raising the temperature on one end but not the other will simply allow the tumor to regrow, and that doesn't solve the problem--or cure the patient.”

The density and placement of nanoparticles in the tumor are critical, according to Dr. Bayazitoglu. "Ideally, you should put nanoparticles at the center of the tumor, then kill it from the center out,” Dr. Bayazitoglu said.

Laser treatment may be effective even if nanoparticles are not used, she noted. "If the tumor has good absorption properties, slow heating can do a good job of killing the cancer, because the heat has time to get inside. If you're doing that, sometimes it's better not to use nanoparticles.”

With so many tissue types and the great range of cancers people face, the importance of accurate simulations cannot be overemphasized, according to the researchers. They hope the ability to calculate scenarios will allow clinicians to find the best laser therapy to produce the perfect heating environment.

Related Links:

Rice University
Nanospectra Biosciences


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.